Search research articles
Contact Us
Filters
Showing results (51-60 of 109) with videos related to
Page
of 11
Sort By:
Oncotarget
|
October 13, 2016
Autophagy mediates proteolysis of NPM1 and HEXIM1 and sensitivity to BET inhibition in AML cells
Min Huang, Jacqueline S Garcia, Daniel Thomas, et al.
British Journal of Haematology
|
February 6, 2016
Predictors of early death and survival among children, adolescents and young adults with acute myeloid leukaemia in California, 1988-2011: a population-based study
Renata Abrahão, Ruth H Keogh, Daphne Y Lichtensztajn, et al.
Clinical Epidemiology
|
November 8, 2019
Longer distance to specialized treatment centers does not adversely affect treatment intensity or outcomes in adult acute myeloid leukemia patients. A Danish national population-based cohort study
Michael Tøstesen, Mette Nørgaard, Jan Maxwell Nørgaard, et al.
Haematologica
|
October 14, 2011
Phase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B-cell acute lymphoblastic leukemia
Michaela Liedtke, Clare J Twist, Bruno C Medeiros, et al.
Current Medical Research and Opinion
|
February 5, 2019
Treatment patterns in patients with acute myeloid leukemia in the United States: a cross-sectional, real-world survey
Bruno C Medeiros, Bhavik J Pandya, Anna Hadfield, et al.
Nature Medicine
|
January 20, 2015
Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia
Steven M Chan, Daniel Thomas, M Ryan Corces-Zimmerman, et al.
Leukemia Research
|
February 7, 2018
Report of the relapsed/refractory cohort of SWOG S0919: A phase 2 study of idarubicin and cytarabine in combination with pravastatin for acute myelogenous leukemia (AML)
Anjali S Advani, Hongli Li, Laura C Michaelis, et al.
Cancer Research
|
June 28, 2017
Unpaired Extracellular Cysteine Mutations of CSF3R Mediate Gain or Loss of Function
Haijiao Zhang, Sophie Means, Anna Reister Schultz, et al.
Cancer Management and Research
|
November 23, 2018
NSAID consumption and risk of acute myeloid leukemia: a national population-based case-control study
Lene Sofie Granfeldt Østgård, Mette Nørgaard, Lars Pedersen, et al.
British Journal of Haematology
|
March 6, 2018
Autoimmune diseases, infections, use of antibiotics and the risk of acute myeloid leukaemia: a national population-based case-control study
Lene S G Østgård, Mette Nørgaard, Lars Pedersen, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 109) with videos related to
Sort By:
Page
of 11
Oncotarget
|
October 13, 2016
Autophagy mediates proteolysis of NPM1 and HEXIM1 and sensitivity to BET inhibition in AML cells
Min Huang, Jacqueline S Garcia, Daniel Thomas, et al.
British Journal of Haematology
|
February 6, 2016
Predictors of early death and survival among children, adolescents and young adults with acute myeloid leukaemia in California, 1988-2011: a population-based study
Renata Abrahão, Ruth H Keogh, Daphne Y Lichtensztajn, et al.
Clinical Epidemiology
|
November 8, 2019
Longer distance to specialized treatment centers does not adversely affect treatment intensity or outcomes in adult acute myeloid leukemia patients. A Danish national population-based cohort study
Michael Tøstesen, Mette Nørgaard, Jan Maxwell Nørgaard, et al.
Haematologica
|
October 14, 2011
Phase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B-cell acute lymphoblastic leukemia
Michaela Liedtke, Clare J Twist, Bruno C Medeiros, et al.
Current Medical Research and Opinion
|
February 5, 2019
Treatment patterns in patients with acute myeloid leukemia in the United States: a cross-sectional, real-world survey
Bruno C Medeiros, Bhavik J Pandya, Anna Hadfield, et al.
Nature Medicine
|
January 20, 2015
Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia
Steven M Chan, Daniel Thomas, M Ryan Corces-Zimmerman, et al.
Leukemia Research
|
February 7, 2018
Report of the relapsed/refractory cohort of SWOG S0919: A phase 2 study of idarubicin and cytarabine in combination with pravastatin for acute myelogenous leukemia (AML)
Anjali S Advani, Hongli Li, Laura C Michaelis, et al.
Cancer Research
|
June 28, 2017
Unpaired Extracellular Cysteine Mutations of CSF3R Mediate Gain or Loss of Function
Haijiao Zhang, Sophie Means, Anna Reister Schultz, et al.
Cancer Management and Research
|
November 23, 2018
NSAID consumption and risk of acute myeloid leukemia: a national population-based case-control study
Lene Sofie Granfeldt Østgård, Mette Nørgaard, Lars Pedersen, et al.
British Journal of Haematology
|
March 6, 2018
Autoimmune diseases, infections, use of antibiotics and the risk of acute myeloid leukaemia: a national population-based case-control study
Lene S G Østgård, Mette Nørgaard, Lars Pedersen, et al.
Page
of 11